Literature DB >> 6853985

Sensitivity of guaiac-impregnated cards for the detection of colorectal neoplasia.

M L Crowley, L D Freeman, M D Mottet, R M Strong, B F Sweeney, R A Brower, S P Sharma, D S Anderson.   

Abstract

The sensitivity of the guaiac-impregnated card, hemoccult II, for the detection of colorectal neoplasia was tested in 213 patients undergoing elective colonoscopy over a 10-month period. Contrary to statements in standard texts as to the high sensitivity of guaiac-impregnated cards for the detection of these tumors, our results demonstrate only a 52% sensitivity for colorectal carcinoma and a 23% sensitivity for adenomatous polyps over 1.0 cm in diameter. We compare these results to other studies testing hemoccult sensitivity in the presence of colorectal neoplasia. This relatively low sensitivity rate emphasizes that the use of guaiac-impregnated cards alone does not exclude colorectal carcinoma in any patient.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6853985     DOI: 10.1097/00004836-198304000-00007

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  12 in total

1.  Evaluation of effectiveness of mass screening for colorectal cancer.

Authors:  M Fujita; R Sugiyama; Y Kumanishi; J Ota; T Horino; Y Nakano; T Taguchi
Journal:  World J Surg       Date:  1990 Sep-Oct       Impact factor: 3.352

2.  [Conventional and molecular screening (fecal tests)].

Authors:  C Pox; K Schulmann; W Schmiegel
Journal:  Internist (Berl)       Date:  2003-03       Impact factor: 0.743

Review 3.  Effect of verification bias on the sensitivity of fecal occult blood testing: a meta-analysis.

Authors:  Alan S Rosman; Mark A Korsten
Journal:  J Gen Intern Med       Date:  2010-05-25       Impact factor: 5.128

4.  Periodic health examination, 1989 update: 2. Early detection of colorectal cancer and problem drinking [corrected].

Authors: 
Journal:  CMAJ       Date:  1989-08-01       Impact factor: 8.262

5.  Symposium: Screening for colorectal cancer.

Authors:  F Macrae; G Ekelund; B P Robra; R Gnauck; H Ribet; J Escourrou; J H Bond; N C Armitage; J B Simon
Journal:  Int J Colorectal Dis       Date:  1986-04       Impact factor: 2.571

6.  Cost effectiveness of HemoQuant versus Hemoccult for colorectal cancer screening.

Authors:  A M Joseph; T W Crowson; E C Rich
Journal:  J Gen Intern Med       Date:  1988 Mar-Apr       Impact factor: 5.128

7.  Colonoscopic detection of early colorectal cancers. Impact of a surgical endoscopy service.

Authors:  W E Longo; G H Ballantyne; I M Modlin
Journal:  Ann Surg       Date:  1988-02       Impact factor: 12.969

Review 8.  The pros and cons of fecal occult blood testing for colorectal neoplasms.

Authors:  J B Simon
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

Review 9.  Colorectal carcinoma and Haemoccult. A study of its value in mass screening using meta-analysis.

Authors:  J Windeler; J Köbberling
Journal:  Int J Colorectal Dis       Date:  1987-11       Impact factor: 2.571

10.  Effect of diet on fecal occult blood testing in patients with colorectal polyps.

Authors:  R G Norfleet
Journal:  Dig Dis Sci       Date:  1986-05       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.